MediCom Oncology Clinical Pearls Podcasts MediCom Oncology
-
- Science
-
MediCom Oncology Clinical Pearl Podcasts provide practical, evidence-based recommendations on real-world issues in the clinical setting, in under three minutes. Leading experts and academic faculty from top research and practice institutions provide guidance to community-based healthcare providers, including oncologists, pharmacists and nurses. Podcasts are brought to you by MediCom Worldwide, Inc., an accredited, independent medical education company.
Podcasts are intended for licensed adult healthcare professionals (HCPs). HCPs should exercise professional judgment in evaluating content, and confirm information before implementing treatment or practice-related changes. Podcasts do not provide medical advice to patients.
-
Third-generation FLT3 inhibitors in clinical development
Dr. Perl provides a brief summary of what is on the horizon for FLT3 inhibitors in AML.
-
CAR T case study in acute myeloid leukemia
Dr. Sallman describes a patient case demonstrating promise in the further study and potential use of CAR T-cell therapy for patients with AML.
-
Key considerations when prescribing midostaurin with a strong CYP3A4 inhibi
Dr. Perl gives guidance on providing optimal patient therapy when prescribing midostaurin with a strong CYP3A4 inhibitor.
-
How to proceed with a patient who presents with idiopathic cytopenia of undetermined significance
In this audio activity, Dr. Goldberg describes his approach to patients with idiopathic or clonal cytopenias of undetermined significance (ICUS and CCUS).
-
When to consider iron chelation therapy for a transplant-eligible patient
Listen as Dr. Goldberg explains his approach to iron chelation therapy in patients who are, or may be within the next 5-10 years, eligible for transplant.
-
53-year-old woman presenting with severe fatigue and bruising
Hematopathologist Dr. Khoury presents a case snapshot showing the complexities of diagnosing AML, describing the importance of morphology, flow cytometry, cytogenetics, and molecular diagnostics.